Thursday, September 29, 2011

Pfizer faces off-patent smoking drug threat -

Pfizer is facing a threat to its top-selling smoking cessation drug Champix from the Bulgarian company that has long marketed the low-cost off-patent medicine from which it was derived.

Posted via email from Jack's posterous


Anonymous said...

it's chanTix, not chamPix

betasheep said...

It's called both. Chantix in the US. Champix in the UK and Europe.